1. Lizhong Decoction Ameliorates Ulcerative Colitis in Mice via Regulation of Plasma and Urine Metabolic Profiling
- Author
-
Shu Jiang, Ling Wang, Yumeng Shen, Yi-Fan Chen, and Jinhua Tao
- Subjects
Salazosulfadimidine ,medicine.drug_class ,Linoleic acid ,Decoction ,Glycerophospholipids ,Arachidonic Acids ,Urine ,Pharmacology ,Bile Acids and Salts ,Mice ,chemistry.chemical_compound ,Glutamates ,medicine ,Animals ,Pharmacology (medical) ,Amino Acids ,Colitis ,Aspartic Acid ,Sphingolipids ,Alanine ,Bile acid ,Terpenes ,Tryptophan ,Dextrans ,General Medicine ,medicine.disease ,Ulcerative colitis ,Linoleic Acids ,Complementary and alternative medicine ,chemistry ,Colitis, Ulcerative ,Arachidonic acid ,Biomarkers ,Drugs, Chinese Herbal - Abstract
OBJECTIVE To elucidate the mechanism of Lizhong Decoction (LZD, ) in treating dextran sodium sulfate (DSS)-induced colitis in mice based on metabonomics. METHODS Thirty-six mice were randomly divided into 6 groups, including normal, model, low- (1.365 g/kg), medium- (4.095 g/kg) and high dose (12.285 g/kg) LZD and salazosulfadimidine (SASP) groups, 6 mice in each group. Colitis model mice were induced by DSS admistration for 7 days, and treated with low, medium and high dose LZD extract and positive drug SASP. Metabolic comparison of DSS-induced colitis and normal mice was investigated by using ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass (UPLC-Q-TOF/MS) combined with Metabolynx™ software. RESULTS The metabolic profiles of plasma and urine in colitis mice were distinctly ameliorated after LZD treatment (P
- Published
- 2021
- Full Text
- View/download PDF